Literature DB >> 33584250

New Mechanistic Insights, Novel Treatment Paradigms, and Clinical Progress in Cerebrovascular Diseases.

Johannes Boltze1, Jaroslaw A Aronowski2, Jerome Badaut3, Marion S Buckwalter4, Mateo Caleo5,6, Michael Chopp7,8, Kunjan R Dave9, Nadine Didwischus1, Rick M Dijkhuizen10, Thorsten R Doeppner11, Jens P Dreier12,13,14,15, Karim Fouad16, Mathias Gelderblom17, Karen Gertz12,18, Dominika Golubczyk19, Barbara A Gregson20, Edith Hamel21, Daniel F Hanley22, Wolfgang Härtig23, Friedhelm C Hummel24,25, Maulana Ikhsan26,27,28, Miroslaw Janowski29, Jukka Jolkkonen30, Saravanan S Karuppagounder31,32, Richard F Keep33, Inga K Koerte34,35, Zaal Kokaia36, Peiying Li37, Fudong Liu38, Ignacio Lizasoain39, Peter Ludewig17, Gerlinde A S Metz40, Axel Montagne41, Andre Obenaus42, Alex Palumbo26,27,28, Monica Pearl43, Miguel Perez-Pinzon9, Anna M Planas44,45, Nikolaus Plesnila46,47,48, Ami P Raval9, Maria A Rueger49, Lauren H Sansing50, Farida Sohrabji51, Charlotte J Stagg52,53, R Anne Stetler54, Ann M Stowe55, Dandan Sun56, Akihiko Taguchi57, Mickael Tanter58, Sabine U Vay49, Raghu Vemuganti59, Denis Vivien60,61, Piotr Walczak29, Jian Wang62, Ye Xiong63, Marietta Zille26,27,28.   

Abstract

The past decade has brought tremendous progress in diagnostic and therapeutic options for cerebrovascular diseases as exemplified by the advent of thrombectomy in ischemic stroke, benefitting a steeply increasing number of stroke patients and potentially paving the way for a renaissance of neuroprotectants. Progress in basic science has been equally impressive. Based on a deeper understanding of pathomechanisms underlying cerebrovascular diseases, new therapeutic targets have been identified and novel treatment strategies such as pre- and post-conditioning methods were developed. Moreover, translationally relevant aspects are increasingly recognized in basic science studies, which is believed to increase their predictive value and the relevance of obtained findings for clinical application.This review reports key results from some of the most remarkable and encouraging achievements in neurovascular research that have been reported at the 10th International Symposium on Neuroprotection and Neurorepair. Basic science topics discussed herein focus on aspects such as neuroinflammation, extracellular vesicles, and the role of sex and age on stroke recovery. Translational reports highlighted endovascular techniques and targeted delivery methods, neurorehabilitation, advanced functional testing approaches for experimental studies, pre-and post-conditioning approaches as well as novel imaging and treatment strategies. Beyond ischemic stroke, particular emphasis was given on activities in the fields of traumatic brain injury and cerebral hemorrhage in which promising preclinical and clinical results have been reported. Although the number of neutral outcomes in clinical trials is still remarkably high when targeting cerebrovascular diseases, we begin to evidence stepwise but continuous progress towards novel treatment options. Advances in preclinical and translational research as reported herein are believed to have formed a solid foundation for this progress.
Copyright © 2021 Boltze, Aronowski, Badaut, Buckwalter, Caleo, Chopp, Dave, Didwischus, Dijkhuizen, Doeppner, Dreier, Fouad, Gelderblom, Gertz, Golubczyk, Gregson, Hamel, Hanley, Härtig, Hummel, Ikhsan, Janowski, Jolkkonen, Karuppagounder, Keep, Koerte, Kokaia, Li, Liu, Lizasoain, Ludewig, Metz, Montagne, Obenaus, Palumbo, Pearl, Perez-Pinzon, Planas, Plesnila, Raval, Rueger, Sansing, Sohrabji, Stagg, Stetler, Stowe, Sun, Taguchi, Tanter, Vay, Vemuganti, Vivien, Walczak, Wang, Xiong and Zille.

Entities:  

Keywords:  cell therapies; dementia; experimental therapy; hemorrhage; neuroprotection; neurorehabilitation; stroke; translational research

Year:  2021        PMID: 33584250      PMCID: PMC7876251          DOI: 10.3389/fnagi.2021.623751

Source DB:  PubMed          Journal:  Front Aging Neurosci        ISSN: 1663-4365            Impact factor:   5.750


  133 in total

1.  Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation.

Authors:  Francesc Miró-Mur; Isabel Pérez-de-Puig; Maura Ferrer-Ferrer; Xabier Urra; Carles Justicia; Angel Chamorro; Anna M Planas
Journal:  Brain Behav Immun       Date:  2015-08-12       Impact factor: 7.217

Review 2.  Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance.

Authors:  R Anne Stetler; Rehana K Leak; Yu Gan; Peiying Li; Feng Zhang; Xiaoming Hu; Zheng Jing; Jun Chen; Michael J Zigmond; Yanqin Gao
Journal:  Prog Neurobiol       Date:  2014-01-02       Impact factor: 11.685

3.  Recent advances in basic and translational stroke research.

Authors:  Johannes Boltze; Alexander Kranz; Daniel-Christoph Wagner; Klaus Reymann; Georg Reiser; David C Hess
Journal:  Expert Rev Neurother       Date:  2011-02       Impact factor: 4.618

4.  Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era.

Authors:  Sean I. Savitz; Jean-Claude Baron; Marc Fisher
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

Review 5.  Spreading depolarization is not an epiphenomenon but the principal mechanism of the cytotoxic edema in various gray matter structures of the brain during stroke.

Authors:  Jens P Dreier; Coline L Lemale; Vasilis Kola; Alon Friedman; Karl Schoknecht
Journal:  Neuropharmacology       Date:  2017-09-21       Impact factor: 5.250

6.  Progressive Histopathological Damage Occurring Up to One Year after Experimental Traumatic Brain Injury Is Associated with Cognitive Decline and Depression-Like Behavior.

Authors:  Xiang Mao; Nicole A Terpolilli; Antonia Wehn; Shiqi Cheng; Farida Hellal; Baiyun Liu; Burcu Seker; Nikolaus Plesnila
Journal:  J Neurotrauma       Date:  2020-02-05       Impact factor: 5.269

7.  Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation.

Authors:  Christoph Kleinschnitz; Nicholas Schwab; Peter Kraft; Ina Hagedorn; Angela Dreykluft; Tobias Schwarz; Madeleine Austinat; Bernhard Nieswandt; Heinz Wiendl; Guido Stoll
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

8.  Preclinical Evaluation of Safety and Biodistribution of Red Cell Microparticles: A Novel Hemostatic Agent.

Authors:  Ashish K Rehni; Vibha Shukla; Hever Navarro Quero; Carlos Bidot; Conner R Haase; Ensign Anise A Crane; Shivam G Patel; Sebastian Koch; Yeon S Ahn; Wenche Jy; Kunjan R Dave
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-04-29       Impact factor: 2.457

9.  Neuronal SIRT1 (Silent Information Regulator 2 Homologue 1) Regulates Glycolysis and Mediates Resveratrol-Induced Ischemic Tolerance.

Authors:  Kevin B Koronowski; Nathalie Khoury; Isabel Saul; Zachary B Loris; Charles H Cohan; Holly M Stradecki-Cohan; Kunjan R Dave; Juan I Young; Miguel A Perez-Pinzon
Journal:  Stroke       Date:  2017-10-10       Impact factor: 7.914

10.  Real-Time MRI Guidance for Reproducible Hyperosmolar Opening of the Blood-Brain Barrier in Mice.

Authors:  Chengyan Chu; Guanshu Liu; Miroslaw Janowski; Jeff W M Bulte; Shen Li; Monica Pearl; Piotr Walczak
Journal:  Front Neurol       Date:  2018-10-26       Impact factor: 4.003

View more
  9 in total

Review 1.  A clinically relevant model of focal embolic cerebral ischemia by thrombus and thrombolysis in rhesus monkeys.

Authors:  Di Wu; Jian Chen; Longfei Wu; Hangil Lee; Jingfei Shi; Mo Zhang; Yanhui Ma; Xiaoduo He; Zixin Zhu; Feng Yan; Chuanjie Wu; Yunxia Duan; Yongjuan Fu; Sijie Li; Xinglong Zhi; Xuxiang Zhang; Shengli Li; Yuchuan Ding; Xunming Ji
Journal:  Nat Protoc       Date:  2022-06-27       Impact factor: 17.021

Review 2.  Traumatic Brain Injury: Ultrastructural Features in Neuronal Ferroptosis, Glial Cell Activation and Polarization, and Blood-Brain Barrier Breakdown.

Authors:  Delong Qin; Junmin Wang; Anh Le; Tom J Wang; Xuemei Chen; Jian Wang
Journal:  Cells       Date:  2021-04-24       Impact factor: 6.600

3.  Phenotype Shifting in Astrocytes Account for Benefits of Intra-Arterial Selective Cooling Infusion in Hypertensive Rats of Ischemic Stroke.

Authors:  Luling Wang; Longfei Wu; Yunxia Duan; Shuaili Xu; Yuyao Yang; Jidong Yin; Ye Lang; Zongen Gao; Chuanjie Wu; Zaigang Lv; Jingfei Shi; Di Wu; Xunming Ji
Journal:  Neurotherapeutics       Date:  2022-01-19       Impact factor: 6.088

4.  Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke.

Authors:  Yali Guan; Pengfei Li; Yingshuo Liu; Lan Guo; Qingwen Wu; Yuefa Cheng
Journal:  Mol Med Rep       Date:  2021-10-13       Impact factor: 2.952

5.  Diet-Induced High Serum Levels of Trimethylamine-N-oxide Enhance the Cellular Inflammatory Response without Exacerbating Acute Intracerebral Hemorrhage Injury in Mice.

Authors:  Caizhen Li; Li Zhu; Yinming Dai; Zhiying Zhang; Leo Huang; Tom J Wang; Peiji Fu; Yinuo Li; Jian Wang; Chao Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-02-16       Impact factor: 6.543

6.  GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/β-Catenin Signaling Pathway.

Authors:  Chengli Liu; Shanshan Sun; Jie Xie; Hui Li; Tianyu Li; Qiqi Wu; Yongsheng Zhang; Xiangjun Bai; Jian Wang; Xin Wang; Zhanfei Li; Wei Wang
Journal:  Mol Neurobiol       Date:  2022-03-31       Impact factor: 5.682

7.  A novel aged mouse model of recurrent intracerebral hemorrhage in the bilateral striatum.

Authors:  Li-Min Wang; Zhi-Hua Liu; Hong-Lei Ren; Xue-Mei Chen; Jun-Min Wang; Hui-Min Cai; Li-Ping Wei; Hui-Hong Tian; Jian Wang; Li-Juan Wang
Journal:  Neural Regen Res       Date:  2023-02       Impact factor: 6.058

Review 8.  Perspectives on the mechanism of pyroptosis after intracerebral hemorrhage.

Authors:  Dengpan Song; Chi-Tai Yeh; Jian Wang; Fuyou Guo
Journal:  Front Immunol       Date:  2022-09-05       Impact factor: 8.786

Review 9.  Dapsone, More than an Effective Neuro and Cytoprotective Drug.

Authors:  Araceli Diaz-Ruiz; Juan Nader-Kawachi; Francisco Calderón-Estrella; Alfonso Mata-Bermudez; Laura Alvarez-Mejia; Camilo Ríos
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.